{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:04:09Z","timestamp":1789020249151,"version":"build-2803163510"},"reference-count":32,"publisher":"Tech Science Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2018,3,5]]},"abstract":"<jats:p>THIS ARTICLE WAS WITHDRAWN BY THE PUBLISHER IN 03\/2021\n         We submitted a manuscript entitled \"Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184\", which was published in the 26(2) issue of <jats:italic>Oncology Research<\/jats:italic>. But now we found some inaccuracies in this manuscript. So after carefully thinking, we are going to withdraw manuscript and try to give more precise model. Thus we decided to withdraw this manuscript with great pity. We sincerely say sorry for all the staffs involved this manuscript because of our action.  All authors agree to withdraw this manuscript.Thank you very much for your time and kind consideration. \nThanks for your time and best wishes.\nLi Jingdong. \n\n   <\/jats:p>","DOI":"10.3727\/096504017x14980882803151","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T11:12:41Z","timestamp":1498561961000},"page":"297-305","source":"Crossref","is-referenced-by-count":35,"title":["[ARTICLE WITHDRAWN] Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184"],"prefix":"10.32604","volume":"26","member":"17807","reference":[{"issue":"5","key":"b1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","year":"2014","journal-title":"Am J Hematol."},{"issue":"9","key":"b2","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/leu.2015.168","article-title":"BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase","volume":"29","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"b3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4143\/crt.2015.436","article-title":"A multi-centric bioequivalence trial in Ph+ chronic myeloid leukemia patients to assess bioequivalence and safety evaluation of generic imatinib mesylate 400 mg tablets","volume":"48","year":"2016","journal-title":"Cancer Res Treat."},{"issue":"23","key":"b4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V126.23.346.346","article-title":"BCR-ABL mutations in chronic myeloid leukemia (CML) patients (pts) with failure and warning to first-and second-line tyrosine kinase inhibitor (TKI) therapy: What is the advantage of next-generation sequencing (NGS) over conventional sequencing?","volume":"126","year":"2015","journal-title":"Blood"},{"issue":"4","key":"b5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1078-0432.CCR-13-3317","article-title":"Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells","volume":"21","year":"2015","journal-title":"Clin Cancer Res."},{"issue":"11","key":"b6","article-title":"Inhibition of T315I Bcr-Abl and other imatinib-resistant Bcr-Abl mutants by the selective Abl kinase inhibitor SGX70393","volume":"108","year":"2006","journal-title":"Blood"},{"issue":"3","key":"b7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2443.2000.00320.x","article-title":"Identification of an imprinted gene, Meg3\/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q","volume":"5","year":"2000","journal-title":"Genes Cells"},{"issue":"3","key":"b8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/en.2009-0657","article-title":"Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: Isoform structure, expression, and functions","volume":"151","year":"2010","journal-title":"Endocrinology"},{"issue":"11","key":"b9","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2003-030222","article-title":"A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"b10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biopha.2013.09.005","article-title":"miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC)","volume":"68","year":"2014","journal-title":"Biomed Pharmacother."},{"issue":"6","key":"b11","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.3892\/ol.2015.3798","article-title":"The significance of microRNA-184 on JAK2\/STAT3 signaling pathway in the formation mechanism of glioblastoma","volume":"10","year":"2015","journal-title":"Oncol Lett."},{"issue":"10","key":"b12","first-page":"12313","article-title":"Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma","volume":"8","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"issue":"6","key":"b13","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/jcb.24055","article-title":"Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation","volume":"113","year":"2012","journal-title":"J Cell Biochem."},{"issue":"1","key":"b14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3892\/ijo.2015.3248","article-title":"The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells","volume":"48","year":"2016","journal-title":"Int J Oncol."},{"issue":"3","key":"b15","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3892\/or.2016.4919","article-title":"Involvement of endoplasmic reticulum stress and p53 in lncRNA MEG3-induced human hepatoma HepG2 cell apoptosis","volume":"36","year":"2016","journal-title":"Oncol Rep."},{"key":"b16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gene.2017.01.004","article-title":"Long noncoding RNA HULC promotes cell proliferation by regulating PI3K\/AKT signaling pathway in chronic myeloid leukemia","volume":"607","year":"2017","journal-title":"Gene"},{"issue":"Database issue","key":"b17","first-page":"D239","article-title":"DIANA-LncBase: Experimentally verified and computationally predicted microRNA targets on long non-coding RNAs","volume":"41","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"b18","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/leu.2015.196","article-title":"\u03b2-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"29","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"b19","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/leu.2015.71","article-title":"Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients","volume":"29","year":"2015","journal-title":"Leukemia"},{"issue":"240","key":"b20","first-page":"43","article-title":"Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors","volume":"2015","journal-title":"Georgian Med News"},{"issue":"34","key":"b21","doi-asserted-by":"crossref","first-page":"54174","DOI":"10.18632\/oncotarget.11099","article-title":"Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"15","key":"b22","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.febslet.2015.04.061","article-title":"Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia","volume":"589","year":"2015","journal-title":"FEBS Lett."},{"issue":"5","key":"b23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4149\/neo_2013_063","article-title":"Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis","volume":"60","year":"2013","journal-title":"Neoplasma"},{"issue":"19","key":"b24","doi-asserted-by":"crossref","first-page":"31714","DOI":"10.18632\/oncotarget.15955","article-title":"Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"b25","first-page":"1269","article-title":"Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways","volume":"89","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"b26","doi-asserted-by":"crossref","first-page":"18337","DOI":"10.18632\/oncotarget.15440","article-title":"TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"b27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3892\/etm.2015.2199","article-title":"microRNA-184 functions as tumor suppressor in renal cell carcinoma","volume":"9","year":"2015","journal-title":"Exp Ther Med."},{"issue":"4","key":"b28","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s13277-013-1395-6","article-title":"The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: A meta-analysis","volume":"35","year":"2014","journal-title":"Tumour Biol."},{"issue":"6","key":"b29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/bcpt.12273","article-title":"Antimetastatic effects of licochalcone B on human bladder carcinoma T24 by inhibition of matrix metalloproteinases-9 and NF-small ka, CyrillicB activity","volume":"115","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"1","key":"b30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00394-013-0520-z","article-title":"Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2","volume":"53","year":"2014","journal-title":"Eur J Nutr."},{"issue":"1","key":"b31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/or.2014.3209","article-title":"Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-kappaB, Ras and matrix metalloproteinase-2 and -9","volume":"32","year":"2014","journal-title":"Oncol Rep."},{"key":"b32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.biopha.2017.02.041","article-title":"lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity","volume":"89","year":"2017","journal-title":"Biomed Pharmacother."}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:35:37Z","timestamp":1733520937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v26n2\/56641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3,5]]}},"alternative-id":["0965-0407(20180305)26:2L.297;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504017x14980882803151","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,5]]}}}